NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals is pleased to announce availability of Methazolamide Tablets and plans to commence shipping June 1, 2012.
“Methazolamide has been in short supply in the US and Fera has been working diligently to ensure patients continue to have access to this important medication” says Phil Hammer, VP of Quality and Manufacturing at Fera.
About Fera Pharmaceuticals, LLC
Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on niche markets. For more information visit www.ferapharma.com.